MARY RYAN: Open Payments
NPI 1518395854 · NEWNAN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,351 in 57 payments from 28 companies in 2025. Trend: 2023 $1,008 · 2024 $1,236 · 2025 $1,351
Food & beverage: $1,351
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 7 | $193 |
| Merck Sharp & Dohme LLC | 8 | $189 |
| Novartis Pharmaceuticals Corporation | 5 | $139 |
| BeOne Medicines USA, Inc. | 3 | $76 |
| Incyte Corporation | 3 | $72 |
| ABBVIE INC. | 3 | $67 |
| Legend Biotech USA Inc. | 3 | $63 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $50 |
| Eisai Inc. | 2 | $40 |
| JAZZ PHARMACEUTICALS INC. | 1 | $36 |
Products named: Enhertu, KEYTRUDA, KISQALI, BRUKINSA, CARVYKTI, Nubeqa, VENCLEXTA, MONJUVI.
Industry payments across GA — which companies pay providers there.
